Skip to content

NEA Management Company, LLC

Follow

13F filer, CIK 1512848, TIMONIUM, MD

NEA Management Company, LLC reported $1,374,035,027 across 26 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 89.57% of the portfolio.

Accepted , ingested 13F-HR 0001072613-26-000901

Period
2026-09-30
Reported value
$1.37B
Holdings
26
Top 10 weight
89.57%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ZNTLnew+3,570,000$9.89M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GLUEreduced-1,000,000-$11.9M
GOSSreduced-987,500-$11.7M
KPTIexited-576,780-$5.64M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001072613-26-000901, largest first. % of portfolio is the value over $1,374,035,027, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,614,486 shares; 2025Q1: 3,614,486 shares; 2025Q2: 3,614,486 shares; 2025Q3: 3,614,486 shares; 2025Q4: 3,614,486 shares; 2026Q1: 3,614,486 shares; 2026Q2: 3,614,486 shares; 2026Q3: 3,614,486 shares 3,614,486$212M15.42%0Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 7,392,301 shares; 2026Q2: 7,392,301 shares; 2026Q3: 7,392,301 shares 7,392,301$192M13.99%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 11,370,376 shares; 2025Q1: 11,370,376 shares; 2025Q2: 13,222,228 shares; 2025Q3: 13,222,228 shares; 2025Q4: 13,222,228 shares; 2026Q1: 13,222,228 shares; 2026Q2: 13,222,228 shares; 2026Q3: 13,222,228 shares 13,222,228$189M13.78%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,250,001 shares; 2025Q1: 1,250,001 shares; 2025Q2: 2,294,261 shares; 2025Q3: 2,144,261 shares; 2025Q4: 3,535,561 shares; 2026Q1: 2,285,561 shares; 2026Q2: 1,710,561 shares; 2026Q3: 1,710,561 shares 1,710,561$136M9.9%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 24,471,264 shares; 2025Q1: 24,471,264 shares; 2025Q2: 24,471,264 shares; 2025Q3: 24,471,264 shares; 2025Q4: 24,471,264 shares; 2026Q1: 24,471,264 shares; 2026Q2: 24,471,264 shares; 2026Q3: 24,471,264 shares 24,471,264$126M9.19%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,613,948 shares; 2025Q1: 2,613,948 shares; 2025Q2: 2,733,719 shares; 2025Q3: 2,733,719 shares; 2025Q4: 3,523,219 shares; 2026Q1: 4,023,219 shares; 2026Q2: 4,023,219 shares; 2026Q3: 4,023,219 shares 4,023,219$109M7.9%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,692,298 shares; 2025Q1: 7,692,298 shares; 2025Q2: 7,692,298 shares; 2025Q3: 7,692,298 shares; 2025Q4: 7,692,298 shares; 2026Q1: 7,692,298 shares; 2026Q2: 7,692,298 shares; 2026Q3: 6,692,298 shares 6,692,298$79.8M5.81%-1,000,000Timeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,969,834 shares; 2025Q1: 3,969,834 shares; 2025Q2: 3,969,834 shares; 2025Q3: 3,969,834 shares; 2025Q4: 3,969,834 shares; 2026Q1: 3,969,834 shares; 2026Q2: 3,969,834 shares; 2026Q3: 3,969,834 shares 3,969,834$64.3M4.68%0Timeline
COURCOURSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,867,769 shares; 2025Q1: 12,867,769 shares; 2025Q2: 12,867,769 shares; 2025Q3: 12,867,769 shares; 2025Q4: 12,867,769 shares; 2026Q1: 12,867,769 shares; 2026Q2: 12,867,769 shares; 2026Q3: 12,867,769 shares 12,867,769$63.8M4.65%0Timeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,587,854 shares; 2025Q1: 1,587,854 shares; 2025Q2: 1,587,854 shares; 2025Q3: 1,058,570 shares; 2025Q4: 1,058,570 shares; 2026Q1: 1,058,570 shares; 2026Q2: 1,058,570 shares; 2026Q3: 1,058,570 shares 1,058,570$58.6M4.26%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,566,081 shares; 2025Q1: 2,195,545 shares; 2025Q2: 4,118,621 shares; 2025Q3: 4,118,621 shares; 2025Q4: 4,118,621 shares; 2026Q1: 4,118,621 shares; 2026Q2: 4,118,621 shares; 2026Q3: 4,118,621 shares 4,118,621$55.5M4.04%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,960,169 shares; 2025Q1: 1,960,169 shares; 2025Q2: 1,960,169 shares; 2025Q3: 1,960,169 shares; 2025Q4: 1,960,169 shares; 2026Q1: 1,960,169 shares; 2026Q2: 1,960,169 shares; 2026Q3: 1,960,169 shares 1,960,169$14.3M1.04%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,090,793 shares; 2025Q1: 1,090,793 shares; 2025Q2: 1,090,793 shares; 2025Q3: 1,090,793 shares; 2025Q4: 1,090,793 shares; 2026Q1: 1,297,893 shares; 2026Q2: 1,297,893 shares; 2026Q3: 1,297,893 shares 1,297,893$12.9M0.94%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,570,000 shares 3,570,000$9.89M0.72%newTimeline
X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,986,793 shares; 2025Q1: 14,986,793 shares; 2025Q2: 499,559 shares; 2025Q3: 2,233,743 shares; 2025Q4: 3,233,743 shares; 2026Q1: 3,233,743 shares; 2026Q2: 3,233,743 shares; 2026Q3: 3,233,743 shares 3,233,743$9.38M0.68%0
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,568,781 shares; 2025Q1: 3,568,781 shares; 2025Q2: 3,568,781 shares; 2025Q3: 3,568,781 shares; 2025Q4: 3,568,781 shares; 2026Q1: 3,568,781 shares; 2026Q2: 3,568,781 shares; 2026Q3: 3,568,781 shares 3,568,781$9.35M0.68%0Timeline
CSBRCHAMPIONS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,713,720 shares; 2025Q1: 1,713,720 shares; 2025Q2: 1,713,720 shares; 2025Q3: 1,713,720 shares; 2025Q4: 1,713,720 shares; 2026Q1: 1,713,720 shares; 2026Q2: 1,713,720 shares; 2026Q3: 1,713,720 shares 1,713,720$8.57M0.62%0Timeline
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,448,757 shares; 2025Q1: 4,448,757 shares; 2025Q2: 4,448,757 shares; 2025Q3: 4,448,757 shares; 2025Q4: 4,448,757 shares; 2026Q1: 4,448,757 shares; 2026Q2: 4,448,757 shares; 2026Q3: 4,448,757 shares 4,448,757$8.39M0.61%0Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,462,586 shares; 2025Q1: 1,462,586 shares; 2025Q2: 1,462,586 shares; 2025Q3: 1,462,586 shares; 2025Q4: 1,462,586 shares; 2026Q1: 1,462,586 shares; 2026Q2: 1,462,586 shares; 2026Q3: 1,462,586 shares 1,462,586$5.4M0.39%0Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,026,083 shares; 2025Q1: 2,026,083 shares; 2025Q2: 2,026,083 shares; 2025Q3: 2,026,083 shares; 2025Q4: 2,026,083 shares; 2026Q1: 2,026,083 shares; 2026Q2: 1,954,440 shares; 2026Q3: 1,954,440 shares 1,954,440$3.42M0.25%0Timeline
MRKRMARKER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,625,678 shares; 2025Q1: 1,625,678 shares; 2025Q2: 1,625,678 shares; 2025Q3: 1,625,678 shares; 2025Q4: 1,625,678 shares; 2026Q1: 1,625,678 shares; 2026Q2: 1,625,678 shares; 2026Q3: 1,625,678 shares 1,625,678$1.74M0.13%0Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 464,398 shares; 2026Q1: 464,398 shares; 2026Q2: 464,398 shares; 2026Q3: 464,398 shares 464,398$1.66M0.12%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 478,548 shares; 2025Q1: 478,548 shares; 2025Q2: 478,548 shares; 2025Q3: 478,548 shares; 2025Q4: 478,548 shares; 2026Q1: 478,548 shares; 2026Q2: 478,548 shares; 2026Q3: 478,548 shares 478,548$1.3M0.09%0Timeline
SNTISENTI BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 442,615 shares; 2025Q1: 3,775,615 shares; 2025Q2: 3,775,615 shares; 2025Q3: 3,775,615 shares; 2025Q4: 3,775,615 shares; 2026Q1: 3,775,615 shares; 2026Q2: 3,775,615 shares; 2026Q3: 3,775,615 shares 3,775,615$1.18M0.09%0Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,005 shares; 2025Q4: 50,005 shares; 2026Q1: 50,005 shares; 2026Q2: 50,005 shares; 2026Q3: 50,005 shares 50,005$229K0.02%0Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 18,093,034 shares; 2025Q1: 18,093,034 shares; 2025Q2: 18,093,034 shares; 2025Q3: 18,093,034 shares; 2025Q4: 18,093,034 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 12,500 shares 12,500$148K0.01%-987,500Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
KPTIKARYOPHARM THERAPEUTICS INC576,780$5.64Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001072613-26-000901 base2026-11-16
13F-HR/A 0001072613-26-000921 addednew holdings2026-11-20